Overview

Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether there is an increased all-cause mortality in sertindole-treated patients in comparison to patients treated with a well-known antipsychotic (risperidone) when used under normal marketed conditions in the treatment of schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Risperidone
Sertindole